386 related articles for article (PubMed ID: 8643970)
1. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Dec; 19(6 Suppl 12):58-63. PubMed ID: 1336623
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin in non-small cell lung cancer: review of the Eastern Cooperative Oncology Group trial and comparison with other carboplatin trials.
Bonomi P
Semin Oncol; 1991 Feb; 18(1 Suppl 2):2-7. PubMed ID: 1846979
[TBL] [Abstract][Full Text] [Related]
5. [Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
Fujita J; Morikawa N; Yamaji Y; Kubo A; Takigawa K; Yamagishi Y; Fujita T; Shiotani T; Takahara J; Irino S
Gan To Kagaku Ryoho; 1992 Jun; 19(6):849-54. PubMed ID: 1318697
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of an etoposide infused over three days: concomitant infusion with cisplatin.
Minami H; Horio Y; Sakai S; Saka H; Shimokata K
Jpn J Clin Oncol; 1991 Dec; 21(6):400-5. PubMed ID: 1666659
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer.
Hansen HH; Rørth M
Cancer Chemother Biol Response Modif; 1992; 13():455-70. PubMed ID: 1327045
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses.
Collery P; Morel M; Desoize B; Millart H; Perdu D; Prevost A; Vallerand H; Pechery C; Choisy H; Etienne JC
Anticancer Res; 1991; 11(4):1529-32. PubMed ID: 1660690
[TBL] [Abstract][Full Text] [Related]
9. Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.
Liew MS; Sia J; Starmans MH; Tafreshi A; Harris S; Feigen M; White S; Zimet A; Lambin P; Boutros PC; Mitchell P; John T
Cancer Med; 2013 Dec; 2(6):916-24. PubMed ID: 24403265
[TBL] [Abstract][Full Text] [Related]
10. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of a pretreated elderly case of small-cell lung carcinoma with continuous five-day intravenous infusion of cisplatin plus etoposide].
Mitsugi K; Mori T; Tamari Y; Tsuda Y; Hirata Y; Otuka T; Nakano S; Niho Y
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2341-4. PubMed ID: 1656891
[TBL] [Abstract][Full Text] [Related]
12. The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer.
Giaccone G; Splinter TA; Kirkpatrick A; Dalesio O; van Zandwijk N; McVie JG
Semin Oncol; 1992 Apr; 19(2 Suppl 6):98-102. PubMed ID: 1329231
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for stage IV non-small cell lung cancer.
Bitran JD; Vokes EE
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1159-68. PubMed ID: 1704879
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
[TBL] [Abstract][Full Text] [Related]
15. [A phase II trial of pirarubicin in untreated disseminated small cell lung cancer. A cooperative study of the French Pneumo-Cancerology Group].
Kleisbauer JP; Taytard A; Balmes P; Reynaud-Gaubert M; Vergeret J; Targhetta R; Thomas P; Bonnaud F; Poirier R
Rev Mal Respir; 1992; 9(2):179-84. PubMed ID: 1314404
[TBL] [Abstract][Full Text] [Related]
16. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Furuse K; Fukuoka M; Kurita Y; Ariyoshi Y; Niitani H; Yoneda S; Fujii M; Hasegawa K; Nishiwaki Y; Tamura M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
[TBL] [Abstract][Full Text] [Related]
18. Platinum/oral etoposide therapy in non-small cell lung cancer.
Furuse K
Oncology; 1992; 49 Suppl 1():63-9; discussion 70. PubMed ID: 1323814
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
Smith IE
Semin Oncol; 1992 Feb; 19(1 Suppl 2):24-7. PubMed ID: 1384136
[TBL] [Abstract][Full Text] [Related]
20. [Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis].
Ono S; Miyazaki T; Nishikawa K; Watanabe K; Hisanaga S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):115-8. PubMed ID: 1309629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
